Literature DB >> 502359

[The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)].

K V Toyka, T Becker, A Fateh-Moghadam, U A Besinger, G Brehm, D Neumeier, K Heininger, K L Birnberger.   

Abstract

The sera of 65 patients with myasthenia gravis (MG) were analysed for antibodies against the nicotinic acetylcholine receptor (ACh-R) using an immunoprecipitation assay (125I-alpha-bungarotoxin bound to human ACh-R as antigen). In 91% of MG sera elevated antibody titers were found ranging up to 500 times reference values. A control group of 77 patients showing various autoimmunological phenomena had ACh-R antibody concentrations within the reference range. The demonstration of antibodies against ACh-R provides a sensitive and highly specific tool for the diagnosis of MG. In addition, the test is helpful in following patients under treatment with immunosuppressive drugs or plasmapheresis. Antibodies against striated, smooth, or heart muscle (indirect immunofluorescence test) are much less sensitive and nonspecific for the diagnosis of MG.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 502359     DOI: 10.1007/bf01478550

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis.

Authors:  V M Monnier; B W Fulpius
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

2.  Some structural properties of the cholinergic receptor protein in its membrane environmental relevant to its function as a pharmacological receptor.

Authors:  J P Changeux; L Benedetti; J P Bourgeois; A Brisson; J Cartaud; P Devaux; H Grünhagen; M Moreau; J L Popot; A Sobel; M Weber
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1976

3.  Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.

Authors:  A G Engel; E H Lambert; F M Howard
Journal:  Mayo Clin Proc       Date:  1977-05       Impact factor: 7.616

Review 4.  Myasthenia gravis (first of two parts).

Authors:  D B Drachman
Journal:  N Engl J Med       Date:  1978-01-19       Impact factor: 91.245

5.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

6.  [Myasthenic syndrome during penicillamine treatment (author's transl)].

Authors:  F Schumm; M Stöhr
Journal:  Klin Wochenschr       Date:  1978-02-01

7.  Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.

Authors:  J Newsom-Davis; A J Pinching; A Vincent; S G Wilson
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

8.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

Authors:  J Lindstrom
Journal:  Clin Immunol Immunopathol       Date:  1977-01

9.  Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.

Authors:  I Kao; D B Drachman
Journal:  Science       Date:  1977-04-29       Impact factor: 47.728

10.  Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.

Authors:  A G Engel; J M Lindstrom; E H Lambert; V A Lennon
Journal:  Neurology       Date:  1977-04       Impact factor: 9.910

View more
  8 in total

1.  Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody.

Authors:  M Halbach; V Hömberg; H J Freund
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

2.  Plasma-separation in myasthenia gravis: a new method of rapid plasma exchange.

Authors:  W Samtleben; U A Besinger; K V Toyka; A Fateh-Moghadam; G Brehm; H J Gurland
Journal:  Klin Wochenschr       Date:  1980-01-02

3.  Treatment of Guillain-Barré syndrome by plasma exchange.

Authors:  E Rumpl; U Mayr; F Gerstenbrand; J M Hackl; P Rosmanith; F Aichner
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  [Correlation of acetylcholine receptor antibodies and clinical severity of myasthenia gravis in combined immunosuppressive therapy].

Authors:  F Schumm; A Fateh-Moghadam; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

5.  Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Authors:  W A Scherbaum; F Schumm; B Maisch; C Müller; A Fateh-Moghadam; S H Flüchter; F J Seif; G F Bottazzo; P A Berg
Journal:  Klin Wochenschr       Date:  1983-05-16

6.  [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].

Authors:  I Kalies; F Heinz; W P Kaschka; K F Druschky; J R Kalden
Journal:  Klin Wochenschr       Date:  1984-04-16

7.  The value of the edrophonium tonography in the diagnosis of myasthenia gravis.

Authors:  S Binder; M Graf; B Mamoli; P Drobec
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

8.  Clinical implementation of anti-acetylcholine receptor antibodies.

Authors:  F E Somnier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.